Home › Companies › UROGEN PHARMA LTD. › 2023-2024
At UROGEN PHARMA LTD.'s shareholder meeting held September 7, 2023, in the 2023-2024 proxy season, 85 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,160 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — UROGEN PHARMA LTD.'s filing reports the proposal as approved, with 81% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: UROGEN PHARMA LTD.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on September 11, 2023.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and UROGEN PHARMA LTD.’s Form 8-K, filed September 11, 2023 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of September 7, 2023: 12 items on UROGEN PHARMA LTD.’s Form 8-K, filed September 11, 2023: 8 elected · 4 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore UROGEN PHARMA LTD. in the interactive database Compare manager voting policies
These tallies are UROGEN PHARMA LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed September 11, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Arie Belldegrun, M.D., FACS | 15,375,490 | -- | -- | 1,446,630 | 5,728,289 | 91% | Elected | — |
| Elect Director: Elizabeth Barrett | 16,643,305 | -- | -- | 178,815 | 5,728,289 | 99% | Elected | — |
| Elect Director: Cynthia M. Butitta | 16,547,666 | -- | -- | 274,454 | 5,728,289 | 98% | Elected | — |
| Elect Director: Fred E. Cohen, M.D. | 16,784,814 | -- | -- | 37,306 | 5,728,289 | 99.7% | Elected | — |
| Elect Director: Stuart Holden, M.D. | 16,791,776 | -- | -- | 30,344 | 5,728,289 | 99.8% | Elected | — |
| Elect Director: James A. Robinson, Jr. | 16,796,331 | -- | -- | 25,789 | 5,728,289 | 99.8% | Elected | — |
| Elect Director: Leana S. Wen, M.D., M.Sc. | 16,795,107 | -- | -- | 27,013 | 5,728,289 | 99.8% | Elected | — |
| Elect Director: Daniel Wildman | 16,796,230 | -- | -- | 25,890 | 5,728,289 | 99.8% | Elected | — |
| 2. 2017 Amended Plan | 13,600,563 | 3,210,096 | 11,461 | -- | 5,728,289 | 81% | Approved | — |
| 3. Performance Stock Units | 13,115,279 | 3,363,390 | 343,451 | -- | 5,728,289 | 80% | Approved | — |
| 4. Advisory vote on the compensation of the Company's named executive officers | 13,668,197 | 3,118,618 | 35,305 | -- | 5,728,289 | 81% | Approved | — |
| 5. Engagement of PricewaterhouseCoopers LLP as independent auditor | 22,507,002 | 16,731 | 26,676 | -- | 0 | 99.9% | Approved | — |
Source: UROGEN PHARMA LTD., Form 8-K, filed with the SEC on September 11, 2023 — read the filing on EDGAR.
Each item below shows how the 85 asset managers that disclosed a UROGEN PHARMA LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of UROGEN PHARMA LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Arie Belldegrun
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Arie Belldegrun, M.D., FACS”): 15,375,490 for, 1,446,630 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 387,618 for, 604,279 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 487,128 | Withhold |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 32,325 | Withhold |
| State Street | 0 | 0 | 0 | 28,865 | Withhold |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 16,400 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 14,883 | Withhold |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 328 | 0 | 0 | 6,500 | Withhold |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 0 | 0 | 0 | 6,484 | Withhold |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 4,624 | Withhold |
| Bridge Builder Trust | 0 | 0 | 0 | 4,007 | Withhold |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 1,616 | Withhold |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Cynthia M. Butitta
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Cynthia M. Butitta”): 16,547,666 for, 274,454 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 975,398 for, 16,499 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 14,883 | Withhold |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 1,616 | Withhold |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Daniel Wildman
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Daniel Wildman”): 16,796,230 for, 25,890 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Elizabeth Barrett
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Elizabeth Barrett”): 16,643,305 for, 178,815 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 977,014 for, 14,883 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 14,883 | Withhold |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Fred E. Cohen
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Fred E. Cohen, M.D.”): 16,784,814 for, 37,306 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: James A. Robinson, Jr.
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: James A. Robinson, Jr.”): 16,796,331 for, 25,789 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Leana S. Wen
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Leana S. Wen, M.D., M.Sc.”): 16,795,107 for, 27,013 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Stuart Holden
UROGEN PHARMA LTD.’s own tally for this item (“Elect Director: Stuart Holden, M.D.”): 16,791,776 for, 30,344 withheld, per its Form 8-K filed September 11, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The shareholders elected the following eight individuals to serve as directors until the Company's next annual meeting of shareholders and until their successors are elected.”
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% of fund votes cast · no official result
Description as filed by funds: I confirm that I do not have a personal interest in the resolution under Proposal 3 and I am not a controlling shareholder of the Company.
The 29 asset managers below reported 471,259 for, 1,185 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 1,185 | 0 | 0 | Against |
| PENN SERIES FUNDS INC | 800 | 0 | 0 | 0 | For |
| TIAA | 716 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
80% Approved · of votes cast
Description as filed by funds: To approve a grant of Performance Stock Units to the Company's CEO under the Company's 2017 Equity Incentive Plan.
UROGEN PHARMA LTD.’s own tally for this item (“3. Performance Stock Units”): 13,115,279 for, 3,363,390 against — passed, per its Form 8-K filed September 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Performance Stock Units The shareholders approved a grant of Performance Stock Units to the Company's Chief Executive Officer under the 2017 Amended Plan.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 0 | 218,434 | 0 | 0 | Against |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 773,463 for, 218,434 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Eversept Partners, LP | 79,850 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 79,850 for.
Combines 4 wordings of this item as funds reported it.
81% Approved · of votes cast
Description as filed by funds: To approve an amendment to the Company's 2017 Equity Incentive Plan to increase the number of ordinary shares authorized for issuance under the plan by 450,000 shares.
UROGEN PHARMA LTD.’s own tally for this item (“2. 2017 Amended Plan”): 13,600,563 for, 3,210,096 against — passed, per its Form 8-K filed September 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved the 2017 Amended Plan.”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 990,281 for, 1,616 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 0 | 1,616 | 0 | 0 | Against |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
81% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.
UROGEN PHARMA LTD.’s own tally for this item (“4. Advisory vote on the compensation of the Company's named executive officers”): 13,668,197 for, 3,118,618 against — passed, per its Form 8-K filed September 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “On an advisory basis, the shareholders approved the compensation paid to the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 0 | 1,616 | 0 | 0 | Against |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Fund voting reports, all 31 managers: 990,202 for, 1,695 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | 0 | 0 | 0 | For |
| MENORA MIVTACHIM HOLDINGS LTD. | 0 | 2,303,030 | 0 | 0 | Against |
| RTW INVESTMENTS, LP | 857,464 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 376,806 | 0 | 0 | 0 | For |
| State Street | 332,529 | 0 | 0 | 0 | For |
| BlackRock | 319,212 | 0 | 0 | 0 | For |
| Citadel | 309,519 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 132,249 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 79,850 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 66,163 | 0 | 0 | 0 | For |
| Renaissance | 59,664 | 0 | 0 | 0 | For |
| J. Goldman & Co LP | 56,846 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 54,146 | 0 | 0 | 0 | For |
| Coastal Bridge Advisors, LLC | 36,484 | 0 | 0 | 0 | For |
| JPMorgan | 35,940 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 35,699 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 29,688 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 0 | 0 | 0 | 0 | Not Voted |
| BBR PARTNERS, LLC | 26,000 | 0 | 0 | 0 | For |
| Northern Trust | 24,205 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 23,945 | 0 | 0 | 0 | For |
| Point72 | 22,445 | 0 | 0 | 0 | For |
| EDGEWOOD MANAGEMENT LLC | 19,000 | 0 | 0 | 0 | For |
| Cresset Asset Management, LLC | 16,716 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
Institutional-manager reports, all 65 managers: 5,642,868 for, 2,318,689 against, 27,174 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To approve the engagement of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as the Company's independent auditor until our 2024 Annual Meeting of Shareholders.
UROGEN PHARMA LTD.’s own tally for this item (“5. Engagement of PricewaterhouseCoopers LLP as independent auditor”): 22,507,002 for, 16,731 against — passed, per its Form 8-K filed September 11, 2023 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The shareholders approved the engagement of PricewaterhouseCoopers LLP as the Company's independent auditor until the Company's 2024 annual meeting of shareholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 31 asset managers below reported 991,897 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 487,128 | 0 | 0 | 0 | For |
| ARK ETF Trust | 218,434 | 0 | 0 | 0 | For |
| Vanguard | 40,509 | 0 | 0 | 0 | For |
| Fidelity | 32,806 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 32,325 | 0 | 0 | 0 | For |
| State Street | 28,865 | 0 | 0 | 0 | For |
| Northern Trust | 26,629 | 0 | 0 | 0 | For |
| Goldman Sachs | 18,880 | 0 | 0 | 0 | For |
| Lincoln Financial | 16,400 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,883 | 0 | 0 | 0 | For |
| Voya | 12,716 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 9,808 | 0 | 0 | 0 | For |
| Equitable | 6,828 | 0 | 0 | 0 | For |
| Brighthouse | 6,617 | 0 | 0 | 0 | For |
| Pacific Life | 6,484 | 0 | 0 | 0 | For |
| John Hancock | 6,461 | 0 | 0 | 0 | For |
| Charles Schwab | 4,624 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,007 | 0 | 0 | 0 | For |
| DWS | 3,028 | 0 | 0 | 0 | For |
| GPS Funds I | 2,634 | 0 | 0 | 0 | For |
| ProShares | 2,376 | 0 | 0 | 0 | For |
| Principal | 2,267 | 0 | 0 | 0 | For |
| Nationwide | 1,768 | 0 | 0 | 0 | For |
| Calvert | 1,616 | 0 | 0 | 0 | For |
| Victory Capital | 1,185 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. All 31 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 23,498,617 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.07% |
| 2 | ARK ETF Trust | 0.93% |
| 3 | Vanguard | 0.17% |
| 4 | Fidelity | 0.14% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.14% |
| 6 | State Street | 0.12% |
| 7 | Northern Trust | 0.11% |
| 8 | Goldman Sachs | 0.08% |
| 9 | Lincoln Financial | 0.07% |
| 10 | CLEARWATER INVESTMENT TRUST | 0.06% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | GREAT POINT PARTNERS LLC | 11.15% |
| 2 | MENORA MIVTACHIM HOLDINGS LTD. | 9.80% |
| 3 | RTW INVESTMENTS, LP | 3.65% |
| 4 | Laurion Capital Management LP | 1.60% |
| 5 | State Street | 1.42% |
| 6 | BlackRock | 1.36% |
| 7 | Citadel | 1.32% |
| 8 | Cerity Partners LLC | 0.56% |
| 9 | Eversept Partners, LP | 0.34% |
| 10 | RICE HALL JAMES & ASSOCIATES, LLC | 0.28% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| RA Capital Management, L.P. | 13.64% | 13G |
| Cowen Financial Products LLC | 11.29% | 13G |
| BlackRock | 10.98% | 13F |
| Morgan Stanley | 10.76% | 13F |
| Soleus Capital Master Fund, L.P. | 9.89% | 13G |
| Menora Mivtachim Holdings Ltd | 9.80% | 13G |
| S Arkin Communications Ltd. | 5.83% | 13D |
| Adage Capital Management, L.P. | 5.43% | 13G |
| Point72 | 4.73% | 13F |
| Monograph Capital Partners I, L.P. | 3.57% | 13D |
Percentages above are of 23,498,617 shares outstanding, as reported by UROGEN PHARMA LTD. on its Form 10-Q dated June 30, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from UROGEN PHARMA LTD.’s 10-Q dated June 30, 2023. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
UROGEN PHARMA LTD. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “UROGEN PHARMA (URGN) 2023 Annual Meeting (2023-2024 season)”, https://proxyvotesnow.com/company/urogen-pharma-ltd/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.